India, April 7 -- image credit- shutterstock

Steris Healthcare, a Mumbai-headquartered pharma startup with operations in Navi Mumbai, has announced a Rs 50 crore multi-pronged growth strategy, including a major expansion into South India, a doubling of production capacity, and plans to launch its Initial Public Offering (IPO) in FY 2026-27.

The company, which recently crossed Rs 100 crore in annual sales, aims to solidify its national presence and enhance its ability to deliver innovative, affordable healthcare solutions.

As part of its strategic expansion, Steris Healthcare will establish a state-of-the-art manufacturing facility in South India, targeting key markets in Kerala, Tamil Nadu, Hyderabad (Telangana), and Bengaluru (Karnata...